An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.
Clinical trial NCT02397395 · WITHDRAWN
Trial details
- NCT number
- NCT02397395
- Sponsor
- Janssen R&D Ireland
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.